Gary I. Grad, MD, Hematologist/Oncologist - Leading Physician of the World

03/29/2015

Trauma is responsible for more global deaths annually than HIV, malaria and tuberculosis combined. Yet healthcare systems in many countries are missing out on life-saving treatments learned on the ...

03/12/2015

Gout is estimated to affect more than 8 million people in the US. While it can be a debilitating condition, a new study suggests there may be a positive side to gout: it could significantly reduce ...

03/04/2015

Among patients with oral anticoagulation-associated intracerebral hemorrhage (bleeding within the brain), reversal of international normalized ratio (INR; a measure used to determine the clotting t...

02/14/2015

UK researchers have launched an ambitious project to analyse samples from over 20,000 blood cancer patients to identify how differences in their cancer cells' DNA can influence the success of treat...

01/29/2015

Early detection of heart attacks aided by gold nanoparticles http://wp.me/p4jVUD-1z

NYU Polytechnic School of Engineering professors have been collaborating with researchers from Peking University on a new test strip that is demonstrating great potential for the early detection of certain heart attacks. Kurt H. Becker, a professor in the Department of Applied Physics and the Department of Mechanical and Aerospace Engineering, and WeiDong Zhu, a research associate professor in the Department of Mechanical and Aerospace Engineering, are helping develop a new colloidal gold test strip for cardiac troponin I (cTn-I) detection. [ 263 more words. ]

01/09/2015

Animal-specific sugar may drive cancer risk in people who eat red meat http://wp.me/p4jVUD-1w

Reearchers at the University of California-San Diego School of Medicine report findings on the role a sugar specific to red meat may play in forming tumors in humans. The researchers wanted to understand why people who eat a lot of red meat are at higher risk for certaincancers, while people who eat other types of meat are not. [ 475 more words. ]

12/31/2014

FDA approves pathogen reduction system to treat platelets http://wp.me/p4jVUD-1t

The U.S. Food and Drug Administration has approved the Intercept Blood System for platelets, the first pathogen reduction system to treat single donor apheresis platelets. The system is for use by blood establishments that collect and manufacture blood and blood components to prepare pathogen reduced platelets for transfusion to reduce the risk of transfusion-transmitted infections. On Dec. 16, the FDA also approved the Intercept Blood System for the preparation of plasma to reduce the risk of transfusion-transmitted infections. [ 375 more words. ]

12/15/2014

Thrombotic effects may delay immediate breast reconstruction after mastectomy http://wp.me/p4jVUD-1q

Immediate breast reconstruction following mastectomy is becoming more prevalent. However, in breast cancerpatients undergoing simultaneous chemotherapy, thrombotic complications can arise that can delay or significantly modify reconstructive plans. Outcomes of cases illustrating potential complications are published in the current issue of Annals of Medicine and Surgery. Chemotherapy is increasingly used to treat larger operable or advanced breast cancer prior to surgery. [ 328 more words. ]

12/02/2014

What is bone marrow? What does bone marrow do? http://wp.me/p4jVUD-1n

Bone marrow is the spongy tissue inside some of the bones in the body, including the hip and thigh bones. Bone marrow contains immature cells, called stem cells. Numerous people with blood cancers such as leukemia,lymphoma, sickle cell anemia and other life-threatening diseases, rely on bone marrow or cord blood transplants to save their life. Healthy bone marrow and blood cells are needed in order to live. [ 6177 more words. ]

11/18/2014

Hepatitis C vaccine shows promise in early clinical trial http://wp.me/p4jVUD-1k

Around 3.2 million Americans have chronic Hepatitis C, making it the most common long-term bloodborne illness in the US. But could a vaccine for the disease be in sight? Researchers reveal how a vaccine has shown promise against hepatitis C infection a phase 1 clinical trial. Hepatitis C is a liver disease caused by the hepatitis C virus (HCV). It is transmitted through contact with the blood of an infected individual, most commonly by sharing needles, syringes or other drug-injecting equipment, or through needle injuries in health care settings. [ 573 more words. ]

10/30/2014

Researchers at NYU Langone Medical Center conclude new drug in development may offer first alternative to standard chemotherapy for T-Cell Acute Lymphoblastic Leukemia. Researchers at NYU Langone M...